{"schema_version":"alpha-profile-public-v1","slug":"barry-p-flannelly-pharm-d","canonical_url":"https://registry.alpha.ac/people/barry-p-flannelly-pharm-d","as_of":"2026-10-05T00:08:48.993371+00:00","published_at":"2026-09-02T02:37:24.381512+00:00","last_reviewed_at":"2026-05-16T00:34:53.954+00:00","identity":{"display_name":"Barry P. Flannelly, Pharm.D.","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Protara Therapeutics, Inc.","company_slug":"protara-therapeutics-inc","exchange":"NASDAQ","ticker":"TARA","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2020-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","effective_date":"2025-04-25","last_checked_at":"2026-04-28T23:48:01.761+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=barry-p-flannelly-pharm-d","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=barry-p-flannelly-pharm-d&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Dr. Barry Flannelly has served as Executive Vice President and General Manager, North America at Incyte Corporation since June 2015, with extensive experience in commercial strategy and business development. He has held key positions at multiple biopharmaceutical companies including Nektar Therapeutics, Onyx Pharmaceuticals, and Novartis."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Protara Therapeutics, Inc.","organizationId":"protara-therapeutics-inc","title":"Director","period":"2020-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Protara Therapeutics, Inc.","company_slug":"protara-therapeutics-inc","exchange":"NASDAQ","ticker":"TARA","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2020-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","effective_date":"2025-04-25","last_checked_at":"2026-04-28T23:48:01.761+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Barry P. Flannelly, Pharm.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:34:54.138615+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TARA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-16T00:34:54.031753+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Barry P. Flannelly, Pharm.D. currently serves as Director at Protara Therapeutics, Inc..","claim_state":"verified","valid_from":"2025-04-25","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:34:54.100451+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TARA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-16T00:34:54.031753+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Compensation"],"claim_text":"Barry P. Flannelly, Pharm.D. serves on Compensation.","claim_state":"verified","valid_from":"2025-04-25","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:34:54.121404+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TARA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-16T00:34:54.031753+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Incyte Corporation","claim_text":"Barry P. Flannelly, Pharm.D. is linked to Incyte Corporation as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:34:54.249274+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TARA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-16T00:34:54.031753+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Executive Vice President and General Manager, North America","claim_text":"Barry P. Flannelly, Pharm.D. is also listed as Executive Vice President and General Manager, North America.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:34:54.22946+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TARA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-16T00:34:54.031753+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Barry P. Flannelly, Pharm.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:34:54.173257+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TARA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-16T00:34:54.031753+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Barry P. Flannelly, Pharm.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:34:54.156117+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TARA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-16T00:34:54.031753+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:barry-p-flannelly-pharm-d","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2020-01-01 · current","organization":"Protara Therapeutics, Inc.","organization_id":"protara-therapeutics-inc"},"claim_text":"Director at Protara Therapeutics, Inc. (2020-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/barry-p-flannelly-pharm-d#profile","url":"https://registry.alpha.ac/people/barry-p-flannelly-pharm-d","dateModified":"2026-05-16T00:34:53.954+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/barry-p-flannelly-pharm-d#person","name":"Barry P. Flannelly, Pharm.D.","url":"https://registry.alpha.ac/people/barry-p-flannelly-pharm-d","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Protara Therapeutics, Inc.","tickerSymbol":"NASDAQ: TARA"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2020-01-01","memberOf":{"@type":"Organization","name":"Protara Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/protara-therapeutics-inc","tickerSymbol":"NASDAQ: TARA"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","name":"TARA DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/barry-p-flannelly-pharm-d"},"registry_intelligence":{"schema_version":"alpha-registry-intelligence-v1","record_version":"unavailable","subject":"alpha:person:barry-p-flannelly-pharm-d","as_of":"unavailable","recorded_at":"unavailable","availability":"unavailable","records":[],"next_offset":null,"limitations":["Structured intelligence is not currently available. Existing published profile evidence remains accessible."]},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T00:34:53.954+00:00","observed_at":"2026-10-05T00:08:48.993371+00:00","freshness_days":142}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"barry-p-flannelly-pharm-d","canonical_url":"https://registry.alpha.ac/people/barry-p-flannelly-pharm-d"},"publication":{"published_at":"2026-09-02T02:37:24.381512+00:00","last_reviewed_at":"2026-05-16T00:34:53.954+00:00","as_of":"2026-10-05T00:08:48.993371+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/barry-p-flannelly-pharm-d","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/barry-p-flannelly-pharm-d","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/barry-p-flannelly-pharm-d.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}